Ishita Drugs and Industries Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was INR 94.46 million compared to INR 101.17 million a year ago. Revenue was INR 95.58 million compared to INR 102.17 million a year ago.

Net income was INR 3.99 million compared to INR 4.3 million a year ago. Basic earnings per share from continuing operations was INR 1.33 compared to INR 1.44 a year ago. Diluted earnings per share from continuing operations was INR 1.33 compared to INR 1.44 a year ago.